Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Janssen-Cilag Ltd
50 - 100 Holmers Farm Way, High Wycombe, Bucks, HP12 4EG
Telephone: +44 (0)1494 567 567
Fax: +44 (0)1494 567 568
WWW: http://www.janssen.co.uk
WWW: http://www.janssen-medinfo.co.uk
Medical Information Direct Line: +44 (0)800 731 8450
Medical Information e-mail: medinfo@janssen-cilag.co.uk
Customer Care direct line: +44 (0)800 731 5550

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 29/03/2011
PIL Vermox 100 mg/5 ml oral suspension

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 29/03/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 07/12/2010 and displayed until 29/03/2011
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 12/08/2010 and displayed until 07/12/2010
Reasons for adding or updating:
  • Change of trade or generic name
  • Change to Further Information section
  • Change to date of revision
  • Change to side-effects
Updated on 12/05/2010 and displayed until 12/08/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 08/01/2009 and displayed until 12/05/2010
Reasons for adding or updating:
  • Change to date of revision
Updated on 10/11/2008 and displayed until 08/01/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 11/07/2005 and displayed until 10/11/2008
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to side-effects
  • Change to drug interactions
  • Change to date of revision
Updated on 09/11/2004 and displayed until 11/07/2005
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
  mebendazole